Angie Szumlinski|June 14, 2022FDA Approves Dermavant’s VTAMA® (tapinarof) cream, 1% for the Treatment of Plaque Psoriasis in Adults: First Topical Novel Chemical Entity Launched for Psoriasis in the U.S. in 25 Years
Angie Szumlinski|June 13, 2022Plastikon Healthcare Issues Voluntary Nationwide Recall of Milk of Magnesia Oral Suspension and Magnesium Hydroxide /Aluminum Hydroxide /Simethicone Oral Suspension Due to Microbial Contamination | FDA
Angie Szumlinski|June 13, 2022Experiment Over: Future of Nursing Home 3-Day Stay Waiver in Doubt Post-PHE